Petrovax Pharm has launched a federal TV media campaign advertising Longidaze®, an innovative medication delivering sophisticated urological and gynecological benefits. The media campaign targets patients experiencing problems with prostatitis.
In November 2018, Longidaze® won out in the category of ‘Medication of Choice for the pathogenetic treatment of chronic prostatitis and relapse prevention’ at the Russian Pharma Awards. This award represents well-deserved recognition of the product’s efficacy as a chronic prostatitis treatment due to its unique formula, mechanism of action, and high quality. Petrovax Pharm continues to promote innovatative, highly effective medications for wide use.
More about Longidaza® on website https://www.longidaza.ru/
 Prindex_Comcon, осень 2017г., Proxima Pharma_RX Test Russia, 2017
 Количество назначений препарата Лонгидаза® врачами (10 специальностей) за 2017 год. Данные Proxima Pharma_RX Test Russia